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Protein ubiquitination has emerged as a pivotal regulatory
reaction that promotes cellular responses toDNAdamage.With
a goal todelineate theDNAdamage signal transduction cascade,
we systematically analyzed the human E2 ubiquitin- and ubiq-
uitin-like-conjugating enzymes for their ability to mobilize the
DNA damage marker 53BP1 onto ionizing radiation-induced
DNA double strand breaks. An RNAi-based screen identified
UBE2U as a candidate regulator of chromatin responses at dou-
ble strand breaks. Further mining of the UBE2U interactome
uncovered its cognate E3 RNF17 as a novel factor that, via the
radiosensitivity, immunodeficiency, dysmorphic features, and
learning difficulties (RIDDLE) syndrome protein RNF168,
enforces DNA damage responses. Our screen allowed us to
uncover new players in the mammalian DNA damage response
and highlights the instrumental roles of ubiquitin machineries
in promoting cell responses to genotoxic stress.
Radiosensitivity, immunodeficiency, dysmorphic features,
and learning difficulties (RIDDLE)4 syndrome is an immunode-
ficiency and radiosensitivity disorder that is manifested by, at
cellular levels, hypersensitivity to ionizing radiation, cell cycle
checkpoint abnormalities, and impaired end joining in the
recombined switch regions (1). Mutations in the E3 ubiquitin
ligase RNF168 were identified as the culprit responsible for the
cellular deficits observed in RIDDLE cells (2) and suggested
that RNF168 may play an important role in mounting cellular
responses to DNA damage. Indeed, RNF168 has emerged as a
core intermediate in the ubiquitin-driven DSB signal transduc-
tion cascade. By depositing ubiquitin adducts onto DSB-flank-
ing chromatin domains, RNF168 assembles DSB response pro-
teins, including 53BP1, BRCA1, and RAD18 (2–4), to drive
DNA damage responses (DDRs). Accordingly, RNF168-null
mice exhibit immunodeficiency, increased radiosensitivity, and
impaired spermatogenesis, highlighting pivotal roles of the E3
ubiquitin ligase in DSB responses and organismal development
(5).
Cell exposure to ionizing radiation (IR) triggers the phos-
phorylation of the histone variant H2AX (also known as
H2AX) (6), a histone mark that initiates a cascade of signaling
events at the local chromatin to mobilize DSB response pro-
teins into punctate structures commonly referred to as IR-in-
duced foci (IRIF) (7). Among the expanding list of DSB
response proteins that concentrate at the damaged chromatin,
RNF168 occupancy at IRIF requires its ability to recognize
ubiquitin adducts, a property attributable to its ubiquitin bind-
ingmotifs that display preference for different ubiquitin species
(2, 3, 8, 9). The ability of RNF168 to dock at DSBs also underlies
its key role in propagating ubiquitin-mediated DSB signals (2,
3) as mutations that inactivate either its ubiquitin binding
motifs or its E3 ubiquitin ligase activity impairedDNAdamage-
induced ubiquitylation and compromised retention of 53BP1
and BRCA1 at DSBs (2, 3, 10). Although the molecular basis
for the RNF168-dependent recruitment of BRCA1 onto DSBs
remains to be defined, RNF168 catalyzes H2A ubiquitination at
Lys13/15 (11), a biochemical reaction regulated by a conserved
acidic patch distal to lysine residues on the H2A/H2B surface
(12, 13), to effectively dock 53BP1 at DSBs (14, 15).
Intriguingly, the observations that DSBs are decorated by
Lys63-based ubiquitin species (16) and that depletion of either
RNF168 or UBC13 suppressed Lys63-ub at IRIF led to the orig-
inal proposal that RNF168 may pair with the E2 ubiquitin-con-
jugating enzyme UBC13 to catalyze Lys63-ub reactions (2, 3),
although subsequent studies suggested otherwise (11, 17–21).
Thus, given the dynamic nature of DSB-associated ubiquityla-
tion (22), together with the complexity of ubiquitin topologies
at play (19, 23–26), the identities and roles of each of the human
ubiquitin machineries in shaping the ubiquitin landscape at
DSBs remain to be defined. To this end, we used an RNA inter-
ference (RNAi)-based approach designed to target ubiquitin
and ubiquitin-like E2 enzymes and have uncovered UBE2U as a
new E2 enzyme important in driving DDRs. Further analysis of
E3-E2 interaction networks led to the identification of the
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RNF17-UBE2U pair as a novel module that promotes DSB sig-
nal transduction via the RIDDLE syndrome protein RNF168.
Results
RNAi Screen Identifies UBE2U as a Novel Regulator of 53BP1
Accumulation at DSBs—Ubiquitylation entails a cascade of
ATP-driven reactions that involve an E1 ubiquitin-activating
enzyme, an E2 ubiquitin-conjugating enzyme, and an E3 ubiq-
uitin ligase. By pairing with their E3 partners, E2 enzymes not
only serve “ubiquitin carrier” functions but also determine the
topology and length of ubiquitin chains, which in turn control
the ultimate fate of its substrates (27). Among the dozens of
human E2s, UBC13 encodes the only known Lys63-ub promot-
ing activity and is arguably the most studied ubiquitin-conju-
gating enzyme in the DDR network (28). Indeed, UBC13 plays
established roles in propagating ubiquitin signals to assemble
53BP1 andBRCA1 atDSBs (29–32). Given the critically impor-
tant roles of regulatory ubiquitylation in DSB signal transduc-
tion and repair processes (33), we were compelled to define the
ubiquitylating activities in the DDR network. Because the
human genome encodes only a few dozens of E2 ubiquitin- and
ubiquitin-like-conjugating enzymes and given the availability
of E2-E3 interacting protein networks (34–36), we reasoned
that a primary screen tailored to target E2 enzymes may allow
us to more efficiently isolate E2-E3 pairs as modules that regu-
late cellular responses to DNA damage.
We took advantage of the fact that IR treatment mobilizes
DNA damage mediator protein 53BP1 into discernable focal
structures, which would allow us to readily single out E2 candi-
dates for further in-depth study.Weused anRNAi approach for
this purpose. We targeted each E2 candidate using a pool of
four siRNAs and assessed IR-induced 53BP1 focus formation in
U2OS cells 48 h following siRNA transfection (Fig. 1A). In sup-
port of the validity of the screen, a number of E2 enzymes with
reported roles in the DSB signal transduction pathway were
identified, including UBC13 (29–32), UBC9 (37, 38), RAD6A
(20), and UBE2D2 (39) (Fig. 1B). Notably, our screen also led to
the identification of UBE2U as a candidate regulator of mam-
malian DDRs.
UBE2U Is Required for DSB Accumulation of DNA Damage
Mediator Proteins—UBE2U encodes a largely uncharacterized
E2 ubiquitin-conjugating enzyme and is composed of a typical
UBC domain at its N terminus (40) with an extension at its C
terminus (Fig. 2A). Cancer-derived UBE2Umutations, many of
which target its catalytic domain, have been catalogued (cBio-
Portal). We deconvoluted the pooled siRNAs and found that
two independent UBE2U-targeting siRNAs suppressed expres-
sion of HA-tagged UBE2U as determined by Western blotting
analysis (Fig. 2B). More importantly, resembling those de-
pleted of UBC13, cells pretreated with the two UBE2U
siRNAs also showed a substantial reduction of 53BP1 IRIF
(Fig. 2C). Our attempt to detect endogenous UBE2U was not
successful, although our rabbit polyclonal anti-UBE2U anti-
bodies that were raised against GST-UBE2U fusion proteins
as well as those from a commercial source (Novus catalogue
number H00148581-B01) specifically recognized overex-
pressed UBE2U (Fig. 2B).
Given the positive roles of UBE2U in supporting IR-induced
53BP1 focus formation, we tested whether UBE2Umight regu-
late the DSB accumulation of other DDR proteins, including
MDC1, RNF8, RNF168, and BRCA1. Interestingly, although
UBE2U depletion compromised BRCA1 and RNF168 IRIF for-
mation (Fig. 2,D and F), knockdown of UBE2U had nomeasur-
able effect on the ability of MDC1 or RNF8 to relocalize to
IR-induced DSBs (Fig. 2E), suggesting that UBE2U operates in
the canonical H2AX-dependent DSB signal transduction path-
way and that itmay regulate chromatin responses atDSBs at the
RNF168 level (Fig. 2G).
To explore the role of UBE2U in DNA damage responses, we
further examined its requirement in checkpoint control follow-
ing cell exposure to IR. We found that UBE2U-depleted cells,
much like those depleted of UBC13, failed to properly arrest at
the G2/M checkpoint following IR challenge (Fig. 3, A and B).
Given our observations that UBE2U may regulate DSB
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FIGURE 1. RNAi screen identifies novel E2 players in the DDR. A and B, HeLa cells transfected with non-targeting siRNAs (siCTR), pooled siRNAs designed to
target each of the human E2s (see Table 1), or those that targeted RNF8 (siRNF8) were irradiated (10 Gy). 4 h post-IR treatment, cells were fixed, permeabilized,
and immunostained with antibodies against 53BP1 and H2AX. Representative images are shown for cells depleted of RNF8 or UBC13 (siUBC13; A), and the
number of 53BP1 foci per cell was quantified and plotted (B). Data represent themean of two independent experiments, and at least 200 nuclei were counted
each time. Error bars represent S.D. n.s., no significance; *, p 0.05 versus control (CTR) cells.
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responses at the RNF168 level (Fig. 2G) and that UBE2U deple-
tion led to marked reduction in RNF168 expression (Figs. 2F
and 3C), we reasoned that if UBE2U enforces DNA damage
responses solely via RNF168 then the partial reduction in
RNF168 protein level in UBE2U-silenced cells should correlate
with milder phenotypic deficits when compared with RNF168
deficiency. To this end, we inactivatedRNF168 orUBE2Uusing
the RNAi approach (Fig. 3C), evaluated cell sensitivity to IR
using the clonogenic survival assay, and assessed the integrity of
the G2/M checkpoint bymeasuring cell arrest at the G2/M bor-
der following exposure to IR-induced DNA damage. Intrigu-
ingly, although RNF168-depleted cells were much more sensi-
tive to IR treatment (Fig. 2D), UBE2U silencing consistently
impaired the G2/M checkpoint to greater extents than that in
RNF168 knockdown cells (Fig. 2E). Together, these lines of
evidence suggest that UBE2U may promote DNA damage
responses via both RNF168-dependent and RNF168-indepen-
dent pathways.
RNAi-based Screen of UBE2U-binding E3s Identifies New
Regulators of DSB Responses—E2 ubiquitin-conjugating
enzymes pair with E3 ubiquitin ligases to confer substrate spec-
ificity. To better understand howUBE2U participates in DDRs,
we set out to identify UBE2U-interacting E3 partners. We took
advantage of the fact that previous E2-E3 interaction studies
have identified a total of 65 putative E3 partners of UBE2U (Fig.
4A) (34–36). To systematically examine whether any of these
E3s may participate in DSB responses, we again designed a
library of siRNAs that targeted these E3 ubiquitin ligases and
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FIGURE 2. UBE2U is a novel factor in DNA damage responses. A, schematic illustration of UBE2U protein domain organization and cancer-associated
mutations on the UBE2U coding sequence (adapted from cBioPortal). B, Western blotting analysis of RNAi-mediated UBE2U silencing. Cells were transfected
with control siRNAs (siCTR) or UBE2U-specific siRNAs either separately (siUBE2U-1 and siUBE2U-2) or as a pool (siUBE2U-mix) together with an expression
construct that encodesHA-UBE2U. 48 h post-transfection, cells were lysed, and proteinswere subjected to SDS-PAGE andWestern blotting experiments using
the indicated antibodies. Asterisk denotes non-specific bands. C andD, UBE2U is required for 53BP1 and BRCA1 IRIF. U2OS cells pretreatedwith two individual
UBE2U-specific siRNAswere irradiated andprocessed for immunostainingexperiments. Cellswere labeledwith antibodies against 53BP1or BRCA1andH2AX
as a DSBmarker. siRNA-mediated depletion of UBC13was used as positive control. E, UBE2U is not required forMDC1 or RNF8 IRIF. U2OS cells transfectedwith
siRNAs that targetedUBE2U (siUBE2U-1 and siUBE2U-2), RNF8 (siRNF8), or non-targeting siRNAs (siCTR) were irradiated (10Gy). 4 h post-IR treatment, cells were
fixed, permeabilized, and immunostained with antibodies against MDC1 and RNF8. Nuclei were visualized with DAPI. F, UBE2U promotes RNF168 IRIF. U2OS
cells pretreated with siRNAs that targeted UBE2U or RNF168 (siRNF168) were processed essentially as in E. G, schematic depicting the canonical DSB signal
transduction pathway where UBE2Umay play a role at the RNF168 level (see text). The percentage of cells positive for IRIF is shown and represents the mean
from at least two independent experiments (see “Experimental Procedures”).
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assessed whether any of the E3s may also be required for IR-
induced 53BP1 foci. We scored the percentage of 53BP1 focus-
positive cells following IR treatment and analyzed the z score
for each RNAi event as described previously (32) (Fig. 4B).
Interestingly, this approach led to the identification of a num-
ber of candidates that were required for 53BP1 IRIF formation,
including RNF17, TRIM34, TRIM65, and RNF10 (Fig. 4C). As a
control, inactivation of RNF168 resulted in marked reduction
of 53BP1 IRIF (Fig. 4C).
E3 Ubiquitin Ligase RNF17 Is Required for DSB Accumula-
tion of 53BP1 and BRCA1—We performed a thorough litera-
ture search and found that none of the E3 ubiquitin ligases have
documented roles in DDRs. Assuming that the E3s promoted
53BP1 in concerted efforts with UBE2U, one would expect that
silencing of the candidate E3s may phenocopy UBE2U inacti-
vation (Fig. 5A). Given the possible link between RNF17 and
RNF168 (see below), we decided to experimentally test whether
RNF17 also promotes DSB responses. Having confirmed the
RNF17-UBE2U interaction (Fig. 5B), we irradiated U2OS cells
following siRNA-mediated depletion of RNF17 and examined
whether the E3 ubiquitin ligase is required for docking of DSB
response factors at DNA breaks. Reminiscent to those seen in
UBE2U-depleted cells, RNF17 inactivation did not noticeably
affect DNA damage-induced focal accumulation of MDC1 and
RNF8 (Fig. 5C). Notably, not only was RNF17 required for
RNF168 IRIF (Fig. 5D) but inactivation of RNF17 compromised
53BP1, BRCA1, and ubiquitin conjugate accumulation at DSBs
(Fig. 5, E–G). Altogether, we concluded that RNF17 promotes
DSB ubiquitylation and enforces DSB accumulation of 53BP1
and BRCA1.
E3 Ubiquitin Ligase RNF17 Regulates mRNA Level of
RNF168—Having established an important role of RNF17 in
facilitating DSB accumulation of tumor suppressors 53BP1 and
BRCA1, we set out to explore the underlying mechanism.
RNF17 is a very large protein with 1623 amino acids and con-
sists of an N-terminal RING finger motif and five Tudor
domains that are distributed along the length of the protein
(Fig. 6A). RNF17 was originally identified in mouse as Mmip-2
(Mad member-interacting protein-2) where it interacts with
transcriptional repressorMad family proteins and regulates the
transcriptional activity of c-Myc (41, 42). Intriguingly, RNF17
inactivation by gene targeting resulted in a complete arrest in
round spermatids, indicating a key role of RNF17 in regulating
spermiogenesis (43). More importantly, a recent study showed
that mouse RNF17 might be involved in the PIWI-interacting
RNA (piRNA) pathway andmay post-transcriptionally regulate
expression of a cohort of genes, including RNF168 (44).
Our observations that the cellular deficits arising from
RNF17 depletion closely resembled those in RIDDLE cells are
in support of the idea that RNF17 plays integral roles in the
H2AX-dependentDSB signal transduction pathway by regulat-
ing RNF168 expression (see “Discussion”). Prompted by this
possibility, we further tested whether RNF17 knockdown may
affect RNF168 expression by Western blotting analysis. Our
effort in detecting endogenous RNF17 was hampered by the
lack of good antibodies either from a commercial source (Fig. 6,
A and B) or those that were raised against bacterially expressed
and purified RNF17 protein fragments (Fig. 6, A and C).
Regardless, we found that RNAi-mediated depletion of UBE2U
orRNF17 led tomarked reduction of RNF168proteins (Fig. 6,D
and E) but did not affect RNF8, an upstream E3 ubiquitin ligase
in the DSB signal transduction pathway. This lends credence to
the idea that UBE2U and RNF17 specifically regulate RNF168.
To test whether UBE2U or RNF17 promotes RNF168 gene
expression, we next quantified the RNF168 mRNA expression
level by real time PCR. Intriguingly, UBE2U and RNF17 deple-
tion reproducibly resulted in marked reduction in the RNF168
mRNA level (Fig. 6F). Taken together, we speculate that
UBE2U and/or RNF17 promotes RNF168 gene expression at
themRNA level, which in turn enforces functions of RNF168 in
DDRs.
To further explore whether roles of UBE2U or RNF17 in
regulatingDDRs are effected via RNF168, we undertook a func-
tional bypass approach to experimentally examine whether
reduction of RNF168 may account for the phenotypic deficits
associated with RNF17 inactivation. Noting the possibility
that the RNF17-UBE2U module may promote DDRs in both
RNF168-dependent and -independent manners, we decided
to evaluate the more immediate RNF168-dependent DSB
responses. We reasoned that if UBE2U or RNF17 promotes
53BP1 IRIF via RNF168 then by reintroducing RNF168 in
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UBE2U- or RNF17-depleted cells one should restore 53BP1
IRIF. To this end, we transiently expressed RNF168 in UBE2U-
or RNF17-silenced cells and scored cells positive for 53BP1
focus formation after IR treatment. Most notably, although
depletion of RNF168, RNF17, and UBE2U impaired 53BP1
IRIF, re-expression of FLAG-tagged RNF168 efficiently allevi-
ated defective IRIF formation of 53BP1 in both UBE2U- and
RNF17-depleted cells (Fig. 6, G and H), indicating that reduc-
tion of RNF168 accounts for, at least in part, the defective DSB
responses seen with UBE2U and RNF17 deficiencies.
Discussion
Cell responses to DSBs entail a sophisticated ubiquitin-
driven DDR network (45). By utilizing an siRNA library
designed to target 37 known and predicted E2s, we systemat-
ically screened for a novel E2 that promotes chromatin
responses at DSBs and have successfully identified UBE2U as a
positive regulator of 53BP1 IRIF formation. Further mining of
the UBE2U interactome uncovered RNF17, among other can-
didate E3 ubiquitin ligases, as a novel regulator of DSB
responses. Together, our E2-guided screen approach not only
uncovered the UBE2U-RNF17 pair as a new E2-E3 module
important in drivingmammalianDDRs but also highlights how
such an approachmay be adaptable to studying and identifying
ubiquitin components in other biological processes.
A recent study showed that RNF17 might be involved in the
piRNA pathway (44). PIWI-interacting RNAs are a class of
small RNAs with length from 24 to 31 nucleotides. These small
RNAs interact with PIWI proteins to form an RNA-induced
silencing complex to repress transposons as well as other pro-
tein-coding genes. The PIWI-piRNA pathway has been exten-
sively studied in transposon silencing in germ lines. Although
the somatic function of PIWI proteins has been documented,
whether somatic piRNAs exist remains obscure (46, 47). Nota-
bly, RNF17 associates with PIWI (48) and was reported to sup-
press the biogenesis of secondary piRNAs (44). Consequently,
upon loss of RNF17, there was a700-fold increase in second-
ary piRNAs that mapped to protein-coding genes. Coinciden-
tally, one of these candidate targets included RNF168, suggest-
ing that RNF17 inactivation might trigger RNF168 gene
silencing through the piRNA pathway (44). Although the
mechanistic basis that details the RNF17-dependent regulation
of RNF168 expression remains to be defined, our observation
that silencing of RNF17 andUBE2U correlated with substantial
reduction in RNF168 mRNA and protein expression is in sup-
port of such a relationship. Because ectopically expressed
RNF168 restored 53BP1 IRIF in RNF17- and UBE2U-depleted
cells, we propose that the RNF17-UBE2U module promotes
DSB signal transduction, at least in part, via regulating RNF168
expression.
The E3 ubiquitin ligase RNF168 was originally identified as
the RIDDLE syndrome protein (1) where RNF168 deficiency
correlated with phenotypic defects in ubiquitin-mediated DSB
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signal transduction (2). As a key intermediate that propagates
DSB signals to orchestrate DDRs, RNF168 is also regulated by
many different factors to ensure that its function is executed
with spatiotemporal control. Indeed, although a number of
ubiquitin machineries, including TRIP12 and USP34, have
been reported to regulate RNF168 turnover (49–51), others
fine-tune RNF168 output by targeting its substrates (52–54).
Importantly, our identification of the UBE2U-RNF17 pair as
regulator of RNF168 expression represents an unprecedented
strategy to stringently keepRNF168 in check. Althoughwe can-
not exclude the possibility that RNF17 may also target other
components to effect DDRs because forced expression of
RNF168 restored 53BP1 IRIF in RNF17-depleted cells, we favor
a model in which RNF17, in concert with UBE2U, suppresses
secondary piRNA biogenesis to facilitate RNF168 expression
(Fig. 7). Together, these regulatory and proteolyticmechanisms
act to regulate RNF168 functions.
Although we envisage that RNF17-UBE2U encodes an
intrinsic RNF168 regulator, it is highly probable that the E3-E2
pair also regulates other cellular factors, especially given the
documented role of RNF17 in the piRNA pathway (44). Indeed,
although silencing of RNF17 or UBE2U led to partial reduction
of RNF168 expression, checkpoint control at the G2/M border
was consistently compromised to greater extents in cells
depleted of UBE2U. These data point to the exciting possibility
that the RNF17-UBE2U module may enforce DDRs in both
RNF168-dependent and -independent manners. Further work
will be necessary to comprehensively understand how the
RNF17-UBE2Upair regulatesmammalian cellular responses to
genotoxic stress.
AlthoughUBE2U remains to be characterized biochemically,
the fact that it associates with many E3 ubiquitin ligases points
to the possibility that it may serve as a catalytic activity in driv-
ing protein ubiquitylation (35, 36, 55). The observation that
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multiple cancer-associated mutations have been identified on
the UBE2U coding sequence, in particular its UBC domain,
argues in favor of a critically important role of the E2 in cell
proliferation and homeostasis. Although we are beginning to
understand how the UBE2U-RNF17 pair may promote DSB
responses, much remains to be elucidated in the UBE2U biol-
ogy because a number of other putative UBE2U-interacting E3s
were also isolated in our E3 screen for their ability to promote
53BP1 IRIF formation. It would be of significant interest to
delineate precisely how the UBE2U network may have evolved
to innervate the DSB signal transduction pathways. In sum, our
RNAi-based screen for ubiquitin machineries important in
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DSB signal transduction events has uncovered a list of novel
ubiquitin components and highlights the important regulatory
role of ubiquitin machineries in genome integrity protection.
Experimental Procedures
Cell Culture—U2OS, 293T, and HeLa cell lines from ATCC
were cultured inDulbecco’smodified Eagle’smedium (DMEM)
supplemented with 10% fetal bovine serum (FBS) at 37 °C in 5%
CO2.
Plasmids and siRNAs—The expression construct of FLAG
epitope-tagged RNF168was described previously (4). For RNAi
experiments, cells were transfected twice with target siRNAs
(Dharmacon) using Oligofectamine according to the manufa-
cturer’s instructions (Invitrogen). The siRNA libraries target-
TABLE 1
Sequences of siRNAs
Sense (5–3)
E2s
UBE2A-homo-257 CGUCCGAGAACAACAUAAUTT
UBE2A-homo-374 CACCUACAGUUAGAUUUGUTT
UBE2A-homo-468 CCAACCUAUGAUGUGUCUUTT
UBE2A-homo-569 GGAGAACAAACGGGAAUAUTT
UBE2B-homo-517 GCAGUGGAAUGCAGUUAUATT
UBE2B-homo-447 GGGAUUUCAAGCGGUUACATT
UBE2B-homo-794 GCACAGCUUUAUCAGGAAATT
UBE2B-homo-668 GGUAGCAUAUGUUUAGAUATT
UBE2C-homo-204 CAUGAUGUCUGGCGAUAAATT
UBE2C-homo-574 CUGCAAGAAACCUACUCAATT
UBE2C-homo-490 GCCUUCUAGGAGAACCCAATT
UBE2C-homo-282 GGAGCAGCUGGAACAGUAUTT
UBE2D1-homo-229 GCUGAAGAGGAUUCAGAAATT
UBE2D1-homo-416 CCAAAGAUUGCUUUCACAATT
UBE2D1-homo-504 CCAGCUCUGACUGUAUCAATT
UBE2D1-homo-579 GUACCAGAUAUUGCACAAATT
UBE2D2-homo-868 GGCAGCAUUUGUCUUGAUATT
UBE2D2-homo-642 CCACAAGGAAUUGAAUGAUTT
UBE2D2-homo-1048 GGACUCAGAAGUAUGCGAUTT
UBE2D2-homo-756 CCCUAUCAGGGUGGAGUAUTT
UBE2D3-homo-486 GGCGCUGAAACGGAUUAAUTT
UBE2D3-homo-727 GGCAGCAUUUGUCUCGAUATT
UBE2D3-homo-599 GACCUAAUGACAGCCCAUATT
UBE2D3-homo-869 CAGACAGAGAUAAGUACAATT
UBE2D4-homo-483 CCGACAGAGAGAAGUACAATT
UBE2D4-homo-342 GCAGCAUCUGCCUUGAUAUTT
UBE2D4-homo-213 GUCCUUACCAAGGAGGUGUTT
UBE2D4-homo-2653 GGGACUGAUUCACAUGUUATT
UBE2E1-homo-444 GGCGAUAACAUCUAUGAAUTT
UBE2E1-homo-738 CCACUCAGUAUAUGACCAATT
UBE2E1-homo-645 GGAGUCCAGCACUAACCAUTT
UBE2E1-homo-556 GCCUCCAAAGGUUACAUUUTT
UBE2E2-homo-510 CACCAGACUAUCCGUUUAATT
UBE2E2-homo-623 CCGGCUUUAACUAUUUCUATT
UBE2E2-homo-325 CGCUGCUAAAUUGUCAACUTT
UBE2E2-homo-713 CCACACAGUACAUGACCAATT
UBE2E3-homo-845 CCCGCUUUGACUAUUUCAATT
UBE2E3-homo-583 GAAGGAGCUAGCUGAAAUATT
UBE2E3-homo-985 GACCAAGAGAUACGCAACATT
UBE2E3-homo-1089 GGACUUCUGUGUAUAUGUUTT
UBE2F-homo-482 GUGCCUCCCAAAGUGAAAUTT
UBE2F-homo-205 GCUAACGCUAGCAAGUAAATT
UBE2F-homo-290 GGGUUUCUGUGAGAGACAATT
UBE2F-homo-711 GGAGGACUUCCGGAAUAAATT
UBE2G1-homo-487 GCCCUCCAGAUACACUUUATT
UBE2G1-homo-593 GCACCCAAAUGUUGAUAAATT
UBE2G1-homo-395 GCUGGCAGAACUCAACAAATT
UBE2G1-homo-695 CCUAUCCACACUGUGGAAATT
UBE2G2-homo-267 CCACUUGAUUACCCGUUAATT
UBE2G2-homo-470 GCAGAGCCCAAUGACGAAATT
UBE2G2-homo-112 GCUGAUGGCCGAGUACAAATT
UBE2G2-homo-345 GGAGAGUCUGCAUUUCCAUTT
UBE2H-homo-545 GGCGGAGUAUGGAAAGUUATT
UBE2H-homo-730 GCCUCAGUUAUUGGCCUAUTT
UBE2H-homo-896 GCUCAUCGGAGAGCUCUAUTT
UBE2H-homo-481 GAUCCUGGGAGGACUUAAUTT
UBE2I-homo-550 GAGGCCUACACGAUUUACUTT
UBE2I-homo-257 GCACGAUGAACCUCAUGAATT
UBE2I-homo-325 GCUUGUUUAAACUACGGAUTT
UBE2I-homo-194 GAGGAAAGCAUGGAGGAAATT
UBE2J1-homo-636 CAGCCUUCGUGGAGUAUAATT
UBE2J1-homo-1034 GCAUCCUUUCAUCAACCUATT
UBE2J1-homo-868 CUAGGCAAAUAAGCUUUAATT
UBE2J1-homo-421 CGCAGCCUUUAGAGGAUAATT
UBE2J2-homo-440 CCAGAGAAUUUCCUUUCAATT
UBE2J2-homo-237 GCUGAAGCAGGACUACCUUTT
UBE2J2-homo-662 GCAGUGCAGAGUUUAGCAUTT
UBE2J2-homo-754 GCACAAGACGAACUCAGUATT
UBE2K-homo-498 GGUCCGGUUUAUCACUAAATT
UBE2K-homo-857 CUGCAACAGAAUUGCUUCUTT
UBE2K-homo-3572 GCAGUUAGUGGACCCAAAUTT
UBE2K-homo-604 GCACGGUAUUAUUGUCAUUTT
UBE2L3-homo-369 CACCGAAGAUCACAUUUAATT
UBE2L3-homo-250 CCAGGUUGAUGAAGCUAAUTT
UBE2L3-homo-437 CCAGUAAUUAGUGCCGAAATT
UBE2L3-homo-2934 GGCAGAGAAUAGGCUUUCUTT
UBE2L6-homo-424 GCUGGUGAAUAGACCGAAUTT
UBE2L6-homo-287 CCUCCCAUGAUCAAAUUCATT
UBE2L6-homo-1161 CUCAGACUGUGAAGUAUAUTT
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FIGURE 7. Working model depicting the role of UBE2U and RNF17 in
RNF168-dependent DSB responses. A, RNF17 and UBE2U may suppress
biogenesis of secondary piRNAs. RNF168 is expressed and catalyzes chroma-
tin ubiquitylation at DSBs to assemble 53BP1 and BRCA1. B, silencing of
RNF17 or UBE2U leads to down-regulation of RNF168 expression. Ubiquitin-
mediatedDSB signals are not propagated, and cells donot efficiently support
53BP1 and BRCA1 IRIF. siCTR, control siRNAs.
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TABLE 1—continued
Sense (5–3)
UBE2L6-homo-165 GAACCUGUCCAGCGAUGAUTT
UBE2M-homo-954 CCAGUCCUUACGAUAAACUTT
UBE2M-homo-875 GUGUGAGACAAUGGUCUAUTT
UBE2M-homo-918 GCAACGUCUGCCUCAACAUTT
UBE2M-homo-723 CCCAAGACGUGUGAUAUCATT
UBE2N-homo-877 CCUCUUUGUUUGCAUUUAATT
UBE2N-homo-613 GGGAAGAAUAUGUUUAGAUTT
UBE2N-homo-2109 GUCCUCAGUUAAUGAUUCUTT
UBE2N-homo-2516 CUGGUAUCCUUCCAAAUAATT
UBE2O-homo-962 GCAGGUUGUAGAGUUGAAATT
UBE2O-homo-2001 GCUGACCACCCUGACUUUATT
UBE2O-homo-3064 GCCUCUACUUGUUUGACAUTT
UBE2O-homo-3750 CCACCCAGUGUGAAACCAATT
UBE2Q1-homo-679 GGACACAGAAGACUUAGAUTT
UBE2Q1-homo-1000 CCAGAUCCUCAAAGAGAAATT
UBE2Q1-homo-1185 CCAUAGAGUCAGUGAUCAUTT
UBE2Q1-homo-493 GCUGGUGGACAUAAAGAAATT
UBE2Q2-homo-677 GCAAUUGAAGUGGUUGAUATT
UBE2Q2-homo-1358 GCAAAUAAAUGCCACCUUATT
UBE2Q2-homo-734 GGAUGUUGAGAUGCUAGAUTT
UBE2Q2-homo-576 CCAUCUUCUUCACCGAUAUTT
UBE2R1-homo-435 CCAAGAUGUGGCACCCUAATT
UBE2R1-homo-550 GCAGAACGUCAGGACCAUUTT
UBE2R1-homo-675 GGGAGUACACAGACAUCAUTT
UBE2R1-homo-1400 CUGCUUUGGUUUGUUUGAATT
UBE2R2-homo-610 CCUGAUGCUCGAGCUGAAATT
UBE2R2-homo-741 GCUACUUCAAGGCGCAUAUTT
UBE2R2-homo-930 GUGAGGACUAUCCUAUUAATT
UBE2R2-homo-1158 GUGCCUUCCAAUGACAACATT
UBE2S-homo-451 CCGAUGGCAUCAAGGUCUUTT
UBE2S-homo-536 GAGGUCUGUUCCGCAUGAATT
UBE2S-homo-598 GCUACUUCCUGACCAAGAUTT
UBE2S-homo-700 ACGUACUGCUGACCAUCAATT
UBE2T-homo-684 CCAGUCAGCUAGUAGGCAUTT
UBE2T-homo-233 CCUGCGAGCUCAAAUAUUATT
UBE2T-homo-738 CCUGGUUCAUCUUAGUUAATT
UBE2T-homo-510 GCUGACAUAUCCUCAGAAUTT
UBE2U-homo-440 GCUCCUCCAGUUGUGAAAUTT
UBE2U-homo-604 GCUAGAGAAUCCAGUGAAUTT
UBE2U-homo-815 GCCACAGAAUACUACAGAATT
UBE2U-homo-898 GCAUCAGAAAGAAUGGAAUTT
UBE2V1-homo-751 GCGCCUAAUGAUGUCUAAATT
UBE2V1-homo-492 GACGAAGACAUGACACUUATT
UBE2V1-homo-1409 GGCCGAAGCAUAGAUUGUATT
UBE2V1-homo-799 GACAGUGUUACAGCAAUUATT
UBE2V2-homo-155 GGUGGACAGGCAUGAUUAUTT
UBE2V2-homo-430 CCACCAGAAGGACAAACAUTT
UBE2V2-homo-249 CUCCGUCAGUUAGAUUUGUTT
UBE2V2-homo-1201 GACUGUGCCAUUUCUAUUATT
UBE2W-homo-215 GGUGCACCAGGUACCUUAUTT
UBE2W-homo-323 CCUGUUCAUCCUCAUGUUUTT
UBE2W-homo-484 GCGAACAUGUAACAAGAAUTT
UBE2W-homo-100 GCAGAAACGACUACAGAAATT
UBE2Z-homo-683 GCAAUGGGAAAGUCUGCUUTT
UBE2Z-homo-755 CCUCAGUGCUCAUCUCUAUTT
UBE2Z-homo-450 GGGAUAUCAUGUCCAUUUATT
UBE2Z-homo-1111 GAGGCUCCAUAAUGAGAAUTT
ATG3-homo-424 GCGGAUGGGUAGAUACAUATT
ATG3-homo-545 GGAAGAAGAUGAAGAUGAATT
ATG3-homo-254 CCACUGUCCAACAUGGCAATT
ATG3-homo-176 CCUCAAGGAAUCAAAGUUUTT
BIRC6-homo-1428 GCAAUUGUACAACAGCUUATT
BIRC6-homo-2777 GCAGUUAACCUCAAAGAAUTT
BIRC6-homo-6793 GCAGUAGCCUUGAUAGAUUTT
BIRC6-homo-10755 GCUGUUGACAGUCUACUUUTT
UFC1-homo-470 CCAUGACCUCCUGAAAUAUTT
UFC1-homo-601 GCCUGACGGAUCAUUUCAATT
UFC1-homo-376 GGUAUGUGGAGAACAACAATT
UFC1-homo-722 GGGCGUCAUCCAACACAAATT
E3s
ANAPC11-homo-278 CAUGGAGAAAGCAUUUCUATT
ANAPC11-homo-466 GACCAGUUCACUACUCAGATT
ANAPC11-homo-409 GUCUAGGGAAGAGUCUUCUTT
BARD1-homo-1282 GUCCGAUGAAUUCAUUAGUTT
BARD1-homo-1795 GCUAGCCACUGCUCAGUAATT
BARD1-homo-541 GCAGGAAACAAGAAGAAUUTT
BFAR-homo-1460 GGAGCCAUUUCUGGAAAGUTT
BFAR-homo-1002 GGAGCUAGAACGUGUCAAATT
BFAR-homo-351 CCCUCAGAUUUCUGUUAGUTT
CADPS2-homo-1022 GCUCAUGGAUAGCCAAAUATT
CADPS2-homo-2028 GCAGCUUGAAGGCUAUACUTT
TABLE 1—continued
Sense (5–3)
CADPS2-homo-2183 CCACAGGUCAAUCAUAUAATT
CGRRF1-homo-740 GGCUCAAGGUCAAUUUCAUTT
CGRRF1-homo-639 GACCGGGAAAUUUAUGAUATT
CGRRF1-homo-545 CCAGUUACCAAGAGAUACUTT
DTX1-homo-2127 CUAGCUACCUAGACAACGUTT
DTX1-homo-564 GCAGUCCAUGCACCAGUUUTT
DTX1-homo-1906 GGGAAGAAGUUCACCGCAATT
DZIP3-homo-1823 GCCUCCUGUUAGCUCUUAUTT
DZIP3-homo-1529 GACCGAAGAUCAGUUUAAATT
DZIP3-homo-2582 GCCUGGAUGAAUUGCAUAUTT
GOLGA2-homo-1163 GUCGGUUAGACAACUACAATT
GOLGA2-homo-683 GAUCCUCGUAUCAGAGAAATT
GOLGA2-homo-519 CUGGACUCCAGCUAUGUAATT
KAT6A-homo-1397 GCGCUAUACUAAUCCAAUATT
KAT6A-homo-4972 CACCCUCUAUGCAGAACAUTT
KAT6A-homo-3756 GCUGAUGACACUCCUAUCUTT
MDM2-homo-475 GGCCAGUAUAUUAUGACUATT
MDM2-homo-912 GGAGAUAUGUUGUGAAAGATT
MDM2-homo-1489 CAGCCAUCAACUUCUAGUATT
ZSWIM2-homo-1520 CAGGUAUCUUCAAGAUUUATT
ZSWIM2-homo-729 GGGAUUCCCUGUAAUAACUTT
ZSWIM2-homo-1787 GAGCACAGCUAAACUUAGUTT
MIB1-homo-883 GGGCAUGUCUGAUCUGAAATT
MIB1-homo-883 CCGAGUACAACAGAUUUAUTT
MIB1-homo-883 GACCUGAGCAUUCGAAAUATT
MIB2-homo-2150 GUGCCAAACAUCGAUGUUATT
MIB2-homo-2226 CGCUAGCUGUGAGAAAGAUTT
MIB2-homo-1486 GGUGGUGAAAGUGUUUGGATT
MUL1-homo-340 GCGUGCCUUAUGCUGUUAUTT
MUL1-homo-801 GGCAUGCAGUACUAUCUAATT
MUL1-homo-451 GCACAAGAUGGUGUGGAAUTT
PCGF1-homo-647 GUCACCGCUUGAUGCUAAATT
PCGF1-homo-503 CCCACUACUAUCGCUAUGATT
PCGF1-homo-706 CCUGAUCACAUGACAAUGATT
PCGF2-homo-839 GAGCCACUGAAGGAAUACUTT
PCGF2-homo-774 CCAAGUUUCUCCGCAACAATT
PCGF2-homo-636 GCCUCUCCAUCGAAUUCUATT
PCGF6-homo-837 GGAGUUCAUUGGUGCUAAUTT
PCGF6-homo-426 GCGCCUGAUUAAUCUCUCUTT
PCGF6-homo-1005 GGAGCAGUAUCAAACUCUATT
PJA1-homo-1368 GACCAAGUGAAACCAGAAATT
PJA1-homo-2165 CAUCUGCUGUAGCGAAUAUTT
PJA1-homo-807 GGCAAGUUUAAAGAUGAUATT
PML-homo-682 CCCGCAAGACCAACAACAUTT
PML-homo-884 GGAGCAGGAUAGUGCCUUUTT
PML-homo-1534 GAGGAUGUCUCCAAUACAATT
RBCK1-homo-1150 GGUGCACCUUCAUCAACAATT
RBCK1-homo-2070 CUGCCACUGAGCUAAAGAUTT
RBCK1-homo-1900 AGAUCGUGGUACAGAAGAATT
RNF10-homo-879 CUGGUCCUAAGAAGAUCAATT
RNF10-homo-1036 CUGCCAAUUUGUGGUGUCUTT
RNF10-homo-2776 CAGCCAAGCUAUUGAAGCATT
RNF11-homo-808 GGGACCCAAUUCGAUUUCUTT
RNF11-homo-595 CGCCAUAUCAGGAACAAGUTT
RNF11-homo-693 GCUCAAAGAAUAGGUCUUATT
RNF113A-homo-1222 GAGGAUGCAAUUCCCAUUATT
RNF113A-homo-497 GUCUCGGCGUGGUUUAUAATT
RNF113A-homo-396 GACCCACAAUCCAAUGAUATT
RNF113b-homo-597 GGGAUUACCAGCCUGACAUTT
RNF113b-homo-703 GGAGAUUGAACGGGAGCUUTT
RNF113b-homo-837 CCAAGUGCAGGCAUUAUUUTT
RNF114-homo-353 GUGGCUACUUGUUCCAAAUTT
RNF114-homo-503 GUGGAACACUGCAAAUUAUTT
RNF114-homo-401 GCCACCAUUAAGGAUGCAUTT
RNF125-homo-839 GCUGGAUCAUUGUAUUACUTT
RNF125-homo-719 GGCACAUAUUCGGACUUGUTT
RNF125-homo-934 GUGGCAGUUUAAUAAGACATT
RNF139-homo-1951 GGAGCCGCUUACAAGAAAUTT
RNF139-homo-1162 GGGACCUCAUUUGCAAUCUTT
RNF139-homo-1271 GGCCUUUAUUGGAUCAACUTT
RNF14-homo-861 CCCUAGCAUACUUGAAUAUTT
RNF14-homo-1682 GGAACUCCCAUAGAGAAAUTT
RNF14-homo-587 CCACAGAAUUUCAAGAUAUTT
RNF144b-homo-815 GAGACAGUCAGCCUAUUGUTT
RNF144b-homo-542 CUGACAUGGUGUGCCUAAATT
RNF144b-homo-976 GGUACUGCCUCCAGAACUUTT
RNF150-homo-1351 GAGGUUUCGAUAUGCAAAUTT
RNF150-homo-1269 GCACUUCGGUUGUGUUUGUTT
RNF150-homo-1605 GCAAGAUGAACAUUCUUAATT
RNF166-homo-363 GCAGCUCUCAUCCUACAAATT
RNF166-homo-411 GACCCUGGCAAAGAUGAGATT
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ing 37 E2s and 64 UBE2U-interacting E3s were purchased from
GenePharma (Table 1). siRNAs for cell depletion of UBC13,
RNF8, and RNF168 were described previously (31, 56).
Sequences for siRNAs that target UBE2U were as follows:
siUBE2U-1,5-GCUCCUCCAGUUGUGAAAUTT-3; siUBE2U-2,
5-GCCACAGAAUACUACAGAATT-3. Sequences of siRNAs
that targeted RNF17 were as follows: siRNF17-1, 5-GAGGA-
ACAAUGGGAAAUAATT-3; siRNF17-2, 5-GAACAU-
AGCAAGAGCAUUAUU-3.
Antibodies—Antibodies againstH2AX, FK2,UBC13, RNF8,
RNF168, andMDC1were described previously (4, 31, 57). Anti-
FLAG (M2) and anti-actin were from Sigma. Anti-BRCA1 (D9)
was purchased from Santa Cruz Biotechnology. Anti-HA anti-
bodies were from Covance. The phosphospecific antibody
against histone H3-Ser(P)10 was purchased from Cell Signaling
Technology. Anti-KAP1 was from BD Biosciences.
Immunofluorescence Staining—To detect IRIF, cells were
irradiated (10 Gy) 48 h post-siRNA transfection. Cells were
subsequently fixed with 3% paraformaldehyde at room temper-
ature for 15 min. Permeabilization was performed using 0.5%
Triton X-100 solution for 1 min prior to standard immuno-
staining procedures. Images were acquired using an Olympus
BX51 fluorescence microscope. The number of 53BP1 foci per
cell was counted using Imaris software.
G2/M Checkpoint Assay—U2OS cells were treated with the
indicated siRNAs twice and subjected to IR treatment (2 Gy) or
left untreated. 1 h post-IR, cells were trypsinized and fixed with
70% ice-cold ethanol. To analyze the mitotic cell population,
cells were stained with primary antibody against histone
H3-Ser(P)10 followed by incubationwith FITC-conjugated goat
anti-rabbit antibodies (Jackson ImmunoResearch Laborato-
ries). DNA content was measured by propidium iodide stain-
ing, and percentage of histone H3-Ser(P)10-positive cells was
determined by flow cytometric analysis on a BD Biosciences
LSR Fortessa analyzer.
RNA Isolation and Real Time PCR Analyses—U2OS cells
were treated with the indicated siRNAs twice. 48 h after the
second transfection, cells were collected by trypsinization.
Total RNA was isolated using TRIzol reagent (Invitrogen, Life
Technologies) following themanufacturer’s protocol. The con-
centration and purity of RNAs were measured by NanoDrop
TABLE 1—continued
Sense (5–3)
RNF166-homo-677 GCUACAAGAGCGCCAACUUTT
RNF17-homo-2793 GCCUGUGCAUAUCUGUAAUTT
RNF17-homo-4174 GAGGAACAAUGGGAAAUAATT
RNF17-homo-4491 GCCUUGCCUUGCAGAAUAUTT
RNF170-homo-1020 GGCAUGCAUUCAGGGAAAUTT
RNF170-homo-800 GCCUGCAUUAUUGCUUACUTT
RNF170-homo-478 GGCCAAAUAUCAAGGUGAATT
RNF181-homo-51 GGCGUCCUAUUUCGAUGAATT
RNF181-homo-440 GACGAGAUAAGGCUCGAAATT
RNF181-homo-363 CCCUGGCUAAGCAAGACAATT
RNF2-homo-842 GGCUAGAGCUUGAUAAUAATT
RNF2-homo-1131 CCAGUUCACUGUAUUAAAUTT
RNF2-homo-620 GGAUCAACAAGCACAAUAATT
RNF25-homo-251 GGACCAGGAUUCACAGUAUTT
RNF25-homo-208 CACCAUGGGAGAUCUACAUTT
RNF25-homo-1021 CCCAGCACAUAUGUGAGAATT
RNF26-homo-1286 GCUUUGUGCUUGUCAAUCUTT
RNF26-homo-1048 CUGGUGGCUUAUGUGAUCATT
RNF26-homo-800 GAGUCUUGCUUUCAUUGCUTT
RNF41-homo-468 GGCACCUCAUUGUGAACAUTT
RNF41-homo-1184 GACGCUACUAUGAGAACUATT
RNF41-homo-881 GAGACAUCCAGCUGCUAAATT
RNF5-homo-194 GACCUUCGAAUGUAAUAUATT
RNF5-homo-308 GCAAGAGUGUCCAGUAUGUTT
RNF5-homo-904 GGAGGAUGGAUUGAGAGAATT
RNFT1-homo-1112 GGGCAUCUGAGAACUUUCATT
RNFT1-homo-1284 GCAUGACCUUAUGGUUUAATT
RNFT1-homo-371 GCAAGCUCCAGAAAUAUAATT
RPSA-homo-755 GGAGGAAUUUCAGGGUGAATT
RPSA-homo-163 GCACCAAUCUUGACUUCCATT
RPSA-homo-586 CUCACUCAGUGGGUUUGAUTT
SYVN1-homo-652 CCAUCUUCAUCAAGUAUGUTT
SYVN1-homo-1726 GGAGACUGCCACUACAGUUTT
SYVN1-homo-943 GCUCCAGGCAAUGGACAAUTT
TRAIP-homo-602 GGAGCAGAUUGAGCUUCUATT
TRAIP-homo-1101 CAGCAUGGUUACUACGAAATT
TRAIP-homo-813 CAGACAGUCUACUCUGAAUTT
TRIM15-homo-893 CGGAGAGAGAUGAGAUUGATT
TRIM15-homo-1247 CUCCUGACCUUGUCAAGAATT
TRIM15-homo-956 CUCAGAUCGAAAGCAAGAATT
TRIM2-homo-390 GCGCUCCAGAACAAUUUCUTT
TRIM2-homo-689 GCUCCCAGAAAUAGAUUCUTT
TRIM2-homo-1637 GGUAGCUGCAUCUACAAAUTT
TRIM23-homo-299 GCCCAUUUGAUCGACAAGUTT
TRIM23-homo-1377 GCCCAUUCCAACAAUUGGUTT
TRIM23-homo-168 GCUAGAGUGUGGAGUUUGUTT
TRIM24-homo-1261 GCUGGACUCUCUAAACAAUTT
TRIM24-homo-779 GAGCUCAUCAGAGGGUAAATT
TRIM24-homo-2095 GACUGUUCAAGUACUAUUATT
TRIM27-homo-1251 GCAGUCAGAUAUGGAGAAATT
TRIM27-homo-1578 GGCAGUGUCUUUGUGGUAUTT
TRIM27-homo-918 GCAGCUGUAUCACUCCUUATT
TRIM28-homo-1828 CUGAGGACUACAACCUUAUTT
TRIM28-homo-1624 GCAGGAAGGCUAUGGCUUUTT
TRIM28-homo-2385 CCAACCAGCGGAAAUGUGATT
TRIM3-homo-2589 CUGGCAACCACUGCUUUAATT
TRIM3-homo-1534 CCACAAGAAUGGCACAUAUTT
TRIM3-homo-2311 GGACUUCCAUAACCAUUCATT
TRIM32-homo-687 CCUUCAGGCAAGGUAUAAATT
TRIM32-homo-1296 GACCAGUCAAGGUGAAGUATT
TRIM32-homo-403 GUGCUAAAGAUCAUUGAUATT
TRIM34-homo-629 GGAAGCUGAGAAGCUGGAATT
TRIM34-homo-728 GCUUAGAAGCAUCCUAAAUTT
TRIM34-homo-1060 GGGUGGAUGUCACACUGAATT
TRIM35-homo-965 GCUUGCAUCUGUGGAAUCUTT
TRIM35-homo-646 GCAGGAGUUUGAUAAGCUUTT
TRIM35-homo-1529 GCACAUCAGUGUCAAGGAATT
TRIM37-homo-1712 GCUGCACAGACUAGUUAUATT
TRIM37-homo-619 GCUACGAGAACUAGUAAAUTT
TRIM37-homo-1030 GCUGAAGAAUAAGCUUAUATT
TRIM38-homo-1064 GUCCACAGCAAUGCGAAUATT
TRIM38-homo-1937 CCAGGUUUAUCAAUAUUCUTT
TRIM38-homo-775 GGGCUCCAUUUCAUAUGGATT
TRIM46-homo-492 GCUGCUUAAGUCAGGCUUUTT
TRIM46-homo-579 CCAAGGUGAUGUGGAGCUUTT
TRIM46-homo-903 CCAACGCCUGGUAUGUCAATT
TRIM47-homo-1351 GCUGUUUGGAACCAAAGGUTT
TRIM47-homo-1092 GGAGCUCAGCUUCACCAAATT
TRIM47-homo-1610 GCUUCUCCGUCUGGUUUCATT
TRIM5-homo-1442 CCUGAUGCAAUGUGUAAUATT
TRIM5-homo-1349 GGCUCUCAAAGUAUCACAUTT
TABLE 1—continued
Sense (5–3)
TRIM5-homo-1298 GGGACAAGAUACCAGACAUTT
TRIM54-homo-854 GGCACAAACACAACUUACUTT
TRIM54-homo-915 CCUCGCAGAACACUAAGAUTT
TRIM54-homo-1236 CCAUGGAAGAGCCACAAAUTT
TRIM65-homo-1044 GGCAGAAUUAUCGCAAUCUTT
TRIM65-homo-1083 CCAACCGUCACUUCUAUCUTT
TRIM65-homo-627 GCUACAGGCCCUGGAAAUATT
TRIM68-homo-1058 GCUGGAUGUUGCAGGAUAUTT
TRIM68-homo-619 GAGGAUGUCUUGAUAAUGUTT
TRIM68-homo-731 CCCUCGAACAUCUGAAGAATT
TRIM74-homo-1016 GGUUCCUCCAUUCAGCUUATT
TRIM74-homo-1057 CCUAUAGCUGGCUCUAUAATT
TRIM74-homo-1173 GCAGAAGUUCACUCAAGCUTT
VPS11-homo-622 GGGCAACUAUCCUGUAACUTT
VPS11-homo-909 GAGGCUACCUUAUCAUUGUTT
VPS11-homo-535 GGCCAUUGGUUUCACAGAUTT
VPS41-homo-1308 CUGGGAAUAUGAAGUUUAUTT
VPS41-homo-1453 GCCACAUUGAUCCGAGAAUTT
VPS41-homo-2349 GCACCGAACUCAAAUGAAATT
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2000 (Thermo Scientific) and agarose gel electrophoresis,
respectively. 1 g of RNA for each sample was reverse tran-
scribed into cDNA using SuperScript II reverse transcriptase
(Invitrogen, Life Technologies) following the manufacturer’s
protocol. Expression of RNF168 mRNAs was determined by
real time PCR. cDNA samples were amplified using iQTM
SYBR Green Supermix on a Bio-Rad iQ5 following the man-
ufacturer’s protocol. Results were derived from three indepen-
dent experiments, each performed in triplicates. Real time PCR
primers for RNF168 and GAPDH (control) were as follows:
RNF168 RT1-forward, 5-AATCTCAGTTTGGGTCAGCC-
3; RNF168 RT1-reverse, 5-TGGAGAAAGTGTCGGCAT-
ATC-3; RNF168 RT2-forward, 5-AGTTCGTCTGCTCAGT-
AAACC-3; RNF168 RT2-reverse, 5-CTTCTTCCTCCTC-
TGCCAAC-3; GAPDH-forward, TGATGACATCAAGAAG-
GTGGTGAAG-3; GAPDH-reverse, 5-TCCTTGGAGGCCA-
TGTAGGCCAT-3.
Clonogenic Survival Assay—U2OS cells were transfected
with siRNAs against UBE2U or RNF168 or control siRNA
twice. 48 h after the second transfection, 500 cells were plated
onto 60-mm dishes and treated with different dosages of IR.
Cells were allowed to grow for 14 days and subjected to Coo-
massie Brilliant Blue staining before colony counting.
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